Sho23
reacted to and commented on
Sho23
reacted to
Sho23
liked
Good morning to all moomoo users! We will deliver notable stocks and the latest rating information from the front market.![]()
Today's strong and weak ingredients
8/19 [Strong material]
3 points to pay attention to in the front field
●The desire to buy while taking profit is dominant is strong
● $Pan Pacific International Holdings (7532.JP)$The financial results for the fiscal year ending 2024/6 were sales of 2 trillion95 billion77 million yen, up 8.2% from the previous fiscal year, and operating profit was 140.1 billion 93 million yen, up 33.2% from the same period.
●Loosening factions, presidential election melee, 11 people willing to run, inward-facing liberals
Stocks that have moved, notable stocks
$SymBio Pharmaceuticals (4582.JP)$has skyrocketed. On the 19th, the company submitted a clinical trial plan notification to the Pharmaceuticals and Medical Devices Agency (PMDA) on 8/5 regarding the international joint phase Ib/II clinical trial of the injectable brincidofovir targeting patients with recurrent or intractable lymphoma, and announced that the trial would begin.
$Heartseed (219A.JP)$has skyrocketed...
Today's strong and weak ingredients
8/19 [Strong material]
3 points to pay attention to in the front field
●The desire to buy while taking profit is dominant is strong
● $Pan Pacific International Holdings (7532.JP)$The financial results for the fiscal year ending 2024/6 were sales of 2 trillion95 billion77 million yen, up 8.2% from the previous fiscal year, and operating profit was 140.1 billion 93 million yen, up 33.2% from the same period.
●Loosening factions, presidential election melee, 11 people willing to run, inward-facing liberals
Stocks that have moved, notable stocks
$SymBio Pharmaceuticals (4582.JP)$has skyrocketed. On the 19th, the company submitted a clinical trial plan notification to the Pharmaceuticals and Medical Devices Agency (PMDA) on 8/5 regarding the international joint phase Ib/II clinical trial of the injectable brincidofovir targeting patients with recurrent or intractable lymphoma, and announced that the trial would begin.
$Heartseed (219A.JP)$has skyrocketed...
Translated
![Today's Moved Stocks, Notable Stocks - 8/19 (Mon)](https://sgsnsimg.moomoo.com/sns_client_feed/181569713/20240819/ac681cd02d9b49f99016295233177255.png/thumb?area=105&is_public=true)
![Today's Moved Stocks, Notable Stocks - 8/19 (Mon)](https://sgsnsimg.moomoo.com/sns_client_feed/181569713/20240819/280a64035f024c358dfc28c9e5b16f21.png/thumb?area=105&is_public=true)
![Today's Moved Stocks, Notable Stocks - 8/19 (Mon)](https://sgsnsimg.moomoo.com/sns_client_feed/181569713/20240513/ce0a4b76f27541b083cf71a59461123c.png?area=105&is_public=true/thumb)
25
1
1